Lyell Immunopharma
LYEL
$2.25
Share price
3.69%
Change (1 day)
5.14%
Change (1 year)
Categories
Lyell Immunopharma (LYEL) - Cash on Hand
Cash on Hand as of December 2023 : $0.54 B
According to Lyell Immunopharma's latest financial reports the company has $0.54 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Lyell Immunopharma - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.54 B | -14.67% |
| 2022-12-31 | $0.64 B | 4.12% |
| 2021-12-31 | $0.61 B | 0.36% |
| 2020-12-31 | $0.61 B | 40.49% |
| 2019-12-31 | $0.43 B |